
Top 20 Companies in Nanotechnology Market In the World in 2025: Market Research Report (2024–2035)
RELEASE DATE: Jul 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Nanotechnology Market Size is projected to grow from USD 7.86 billion in 2024 to USD 193.56 billion by 2035, at a CAGR of 33.81% during the forecast period 2025–2035. The need for diabetes medications is rising as the disease's prevalence rises. Additionally, their demand is rising as a result of the government's initiatives and programs raising awareness.
Introduction
Diabetes is a long-term metabolic condition marked by elevated blood glucose levels that seriously harms the heart, blood vessels, kidneys, eyes, and neurological system. When the body becomes insulin resistant or produces insufficient amounts of insulin, type 2 diabetes results. In the Americas, diabetes affects 62 million individuals, most of whom reside in low- and middle-income nations. Each year, diabetes is directly to blame for 284,049 deaths. Technological developments, increased acceptance rates in emerging nations, and a growth in the number of people with diabetes might all contribute to a more strong worldwide market. Moreover, higher rates of obesity, sedentary lifestyle adoption, and bad diet intake are predicted to raise the incidence of diabetes and support industry expansion. The growing number of people with diabetes, technological development, rising sales of new medications, and a rising rate of acceptance in developing nations are the main factors propelling the nanotechnologys market.
Key Market Trends:
Growing use of nanoparticles in medication administration
Drug delivery and medical device usage of nanomaterials is accelerating due to the growing need for effective and affordable healthcare treatment and diagnostics. The growing use of large-sized materials in drug administration presents a number of difficulties, such as in-vivo instability, poor body absorption, problems with target-specific delivery and tonic efficacy, low bioavailability, poor solubility, and likely negative pharmacological effects. Thus, nanotechnology is important for drug formulations and improved medicine. Additionally, nanotechnology improves the shelf-life, thermostability, and resistance to humidity fluctuations of current medications, which lowers transportation costs and even the necessary dosages. Consequently, the need for nanotechnology is growing in order to administer drugs more effectively and efficiently.
Increasing prevalence of long-term conditions, including cancer and heart disease
The market for drug delivery via nanotechnology is booming as a result of the rising incidence of chronic illnesses like cancer, heart disease, and neurological conditions. For example, the Sudden Cardiac Arrest Foundation estimates that CVD was responsible for 19.1 million fatalities worldwide in 2020. The prevalence rate, adjusted for age, was 7354.1 per 100,000. Because nanotechnology may deliver medications with reduced side effects and increased efficacy, it presents a viable way to address the complexity of these diseases. The need for medication delivery systems based on nanotechnology is therefore anticipated to increase, giving companies in this industry the chance to create cutting-edge goods and solutions to satisfy the rising demands of the healthcare industry.
Nanotechnology Market Size & Statistics
The market for nanotechnology was estimated to be worth USD 7.86 billion in 2024.
The market is going to expand at a CAGR of 33.81% between 2025 and 2035.
The Global Nanotechnology Market is anticipated to reach USD 193.56 billion by 2035.
North America is expected to generate the highest demand during the forecast period in the nanotechnology market
Asia-pacific is expected to grow the fastest during the forecast period in the nanotechnology market.
Regional growth and demand
Asia-pacific is expected to grow the fastest during the forecast period in the nanotechnology market. Asia-Pacific is home to the greatest population in the world, and as a result, there is a greater need for nanomaterials in the production of various electronics, medical devices, textiles, and automobiles. Furthermore, the demand for the materials needed for nanotechnology is anticipated to increase in the upcoming years due to the growing government investments in the Asia Pacific region's energy and power sector development. Because so many different businesses have large manufacturing facilities in places like China, India, South Korea, and Japan, there is a comparatively strong demand for nanomaterials.
North America is expected to generate the highest demand during the forecast period in the nanotechnology market. The expansion of the nanotechnology market in North America has been driven by the region's industrial development as well as the increased acceptance of new and sophisticated technologies in production facilities. The U.S. government has been instrumental in bringing cutting-edge nanotechnology to the industrial sector, which has stimulated market expansion. The demand for a variety of cutting-edge electronic devices, sensors, and photonic devices has surged as a result of customers' higher standard of living and increasing disposable income. Because of the growing need for smaller devices in the healthcare industry, the nanotechnology market is expanding due to the existence of sophisticated healthcare infrastructure and improved access to developed medical facilities.
Top 20 Companies Leading the Nanotechnology Market
- Altair Nanotechnologies Inc.
- Applied Nanotech Inc.
- Advanced Nano Products Co., Ltd.
- Boehringer Ingelheim
- Biosensors International Group Ltd.
- DuPont de Nemours, Inc.
- BASF SE
- Arkema S.A.
- Nano Magic Inc.
- QuantumSphere, Inc.
- Nanosys Inc.
- Nanophase Technologies Corporation
- Oxford Instruments PLC
- Nanoco Group PLC
- Showa Denko KK
- Thermo Fisher Scientific Inc.
- Asahi Kasei Corporation
- eSpin Technologies Inc.
- Imina Technologies SA
- Nanonics Imaging Ltd.
- Altair Nanotechnologies
Headquarters - USA
Altair Nanotechnologies, a pioneer in energy storage systems based on nanotechnology, is headquartered in Nevada, USA. Advanced lithium-ion batteries and nano-engineered materials for electric vehicles, industrial power solutions, and grid stabilization are the company's areas of expertise. Its unique nano-lithium-titanate technology is perfect for high-performance applications since it has a long cycle life and quick charge/discharge capabilities. Altair's solutions help achieve efficient power management and sustainable energy goals. By concentrating on scalable nanotech solutions, the company works with OEMs and utilities to implement smart energy infrastructure. Altair's contributions to the global nanotechnology sector demonstrate its dedication to using molecular-level engineering to address pressing energy issues.
- Applied Nanotech Inc
Headquarters – France
Applied Nanotech Inc. is a Texas-based company that creates innovative nanotechnology solutions for sensors, electronics, and thermal control. Carbon foils, copper-based nanocomposites, and VOC sensors made for high-performance industrial applications are all part of the company's portfolio. Its exclusive Copper StayCleanTM solution is a prime example of nanoscale innovation in surface cleaning and protection. In order to incorporate nanomaterials into flexible electronics, display technologies, and additive manufacturing, Applied Nanotech works with manufacturers. The company improves the durability, conductivity, and efficiency of its products by tackling issues at the molecular level. Its dedication to commercializing cutting-edge materials that enhance daily functionality and sustainability defines its place in the global nanotechnology market.
- Advanced Nano Products (ANP),
Headquarters – South Korea
Advanced Nano Products (ANP), based in Sejong, South Korea, is a pioneer in the development of materials based on nanotechnology for use in electronics, energy, and display systems. The company manufactures conductive inks, high-purity nano silver, and indium tin oxide (ITO) for use in printed electronics, touchscreens, and solar cells. ANP's emphasis on human-centered and environmentally friendly technologies is in line with international sustainability objectives. Its R&D activities propel innovations in smart devices and renewable energy, establishing it as a major force in the worldwide nanotechnology sector. ANP incorporates nanotechnology into commonplace items as part of its dedication to ongoing innovation, improving performance, cutting waste, and opening the door for next-generation consumer experiences.
4.Biosensors International
Headquarters - Singapore
Biosensors International is a Singapore-based medical device firm that uses nanotechnology to improve critical care and interventional cardiology. Nanoscale coatings are used in its drug-eluting and biodegradable polymer stents to lower systemic exposure and enhance patient outcomes. By using nanomaterials into vascular therapeutics, the company's research improves healing and biocompatibility. In order to provide minimally intrusive solutions, Biosensors International has established a global distribution network and works with hospitals. Its contributions to the worldwide market for nanotechnology demonstrate how revolutionary nanoscale engineering may be in the medical field. Biosensors is setting norms in cardiovascular treatment and medical device design by fusing innovation with clinical efficacy.
- Boehringer Ingelheim
Headquarters - Germany
Germany-based Boehringer Ingelheim has a significant role in the market for diabetic drugs, especially with its oral drugs, such as Jardiance and Glyxambi. Co-developed with Eli Lilly, Jardiance is an SGLT2 inhibitor that has shown advantages for heart and kidney health in people with Type 2 diabetes. The business specializes in innovative pharmacological techniques and partnerships fueled by research. Boehringer's competitive edge is strengthened by its dedication to cardio-renal-metabolic care and its growing array of diabetic treatments. To enhance adherence and results, it also makes investments in patient education and digital health. Boehringer continues to be an important participant in the treatment of diabetes by placing a high priority on innovation and international collaborations.
Are you ready to discover more about the nanotechnology market?
The report provides an in-depth analysis of the leading companies operating in the global nanotechnology market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Altair Nanotechnologies Inc.
Business Overview
Company Snapshot
Products Overview
Company Market Share Analysis
Company Coverage Portfolio
Financial Analysis
Recent Developments
Merger and Acquisitions
SWOT Analysis
- Applied Nanotech Inc.
- Advanced Nano Products Co., Ltd.
- Bruker Corporation
- Boehringer Ingelheim
- DuPont de Nemours, Inc.
- BASF SE
- Arkema S.A.
- Nano Magic Inc.
- Others.
Conclusion
The growing demand in electronics, energy, and healthcare is propelling the global nanotechnology market toward a revolutionary phase. The effectiveness and stability of pharmaceuticals are being enhanced by developments in nano-enabled drug delivery, particularly in the treatment of chronic illnesses like cancer and heart disease. Governments and businesses in North America and Asia-Pacific are making significant investments in nanotech advancements, expanding their use in the production of automobiles, textiles, and medical devices.
Need help to buy this report?